ProMetic's PBI-4050 Granted Orphan Drug Designation by EC for Treatment of Idiopathic Pulmonary Fibrosis
October 13, 2015 at 06:43 AM EDT
ProMetic Life Sciences Inc. (OTC: PFSCF) announced today that an orphan drug designation status has been granted for its lead drug ...